Skip to main content

Table 3 Incidences and hazard ratios of herpes zoster by age, sex and comorbidity in alcoholic fatty liver and non-alcoholic fatty liver groups

From: Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease

Variables

Herpes zoster

cHR

(95% CI)

aHR

(95% CI)

Event

PY

IR

Alcoholic fatty liver

 Sex

  Female

208

19,111

10.88

1.00

(reference)

1.00

(reference)

  Male

298

47,198

6.31

0.62

(0.52, 0.74)***

0.83

(0.69, 1.00)

Age, year

 20–29

11

5090

2.16

1.00

(reference)

1.00

(reference)

 30–39

53

15,259

3.47

1.74

(0.91, 3.33)

1.76

(0.92, 3.37)

 40–49

132

20,479

6.45

3.15

(1.70, 5.82)***

2.97

(1.60, 5.51)***

 50–59

170

15,894

10.70

5.54

(3.01, 10.19)***

4.79

(2.59, 8.85)***

 60–69

95

6609

14.37

7.97

(4.27, 14.89)***

6.35

(3.37, 11.99)***

  > 69

45

2978

15.11

10.00

(5.19, 19.42)***

7.76

(3.96, 15.22)***

Comorbidities

 Diabetes mellitus

  No

391

55,367

7.06

1.00

(reference)

1.00

(reference)

  Yes

115

10,945

10.51

2.12

(1.72, 2.61)***

1.32

(1.06, 1.65)*

 Chronic kidney disease

  No

499

65,472

7.62

1.00

(reference)

1.00

(reference)

  Yes

7

837

8.36

1.86

(0.88, 3.93)

1.18

(0.56, 2.50)

 Coronary artery disease

  No

395

57,494

6.87

1.00

(reference)

1.00

(reference)

  Yes

111

8816

12.59

2.58

(2.08, 3.19)***

1.49

(1.19, 1.88)***

 Cancer

  No

496

65,300

7.60

1.00

(reference)

1.00

(reference)

  Yes

10

1009

9.91

1.87

(1.00, 3.49)

1.37

(0.73, 2.58)

 Obesity

  No

487

65,018

7.49

1.00

(reference)

1.00

(reference)

  Yes

19

1291

14.71

2.90

(1.83, 4.59)***

3.00

(1.86, 4.83)***

 Depression

  No

453

61,521

7.36

1.00

(reference)

1.00

(reference)

  Yes

53

4789

11.07

2.13

(1.60, 2.83)***

1.50

(1.12, 2.02)**

Non-alcoholic fatty liver

 Sex

  Female

2488

211,826

11.75

1.00

(reference)

1.00

(reference)

  Male

2352

279,318

8.42

0.72

(0.68, 0.77)***

0.96

(0.90, 1.02)

Age, year

 20–29

163

40,238

4.05

1.00

(reference)

1.00

(reference)

 30–39

414

87,785

4.72

1.13

(0.94, 1.35)

1.12

(0.93, 1.34)

 40–49

914

121,055

7.55

1.76

(1.49, 2.08)***

1.66

(1.40, 1.96)***

 50–59

1525

122,712

12.43

3.19

(2.71, 3.75)***

2.79

(2.37, 3.29)***

 60–69

1116

74,190

15.04

4.06

(3.44, 4.78)***

3.32

(2.81, 3.94)***

  > 69

708

45,165

15.68

5.37

(4.53, 6.37)***

4.17

(3.50, 4.98)***

Comorbidities

 Diabetes mellitus

  No

3486

381,992

9.13

1.00

(reference)

1.00

(reference)

  Yes

1354

109,154

12.40

1.77

(1.66, 1.88)***

1.28

(1.20, 1.36)***

 Chronic kidney disease

  No

4751

483,715

9.82

1.00

(reference)

1.00

(reference)

  Yes

89

7430

11.98

2.10

(1.70, 2.60)***

1.35

(1.10, 1.67)**

 Coronary artery disease

  No

3584

403,266

8.89

1.00

(reference)

1.00

(reference)

  Yes

1256

87,878

14.29

2.18

(2.04, 2.33)***

1.41

(1.31, 1.51)***

 Cancer

  No

4606

475,585

9.68

1.00

(reference)

1.00

(reference)

  Yes

234

15,559

15.04

2.02

(1.77, 2.30)***

1.52

(1.33, 1.74)***

 Obesity

  No

4703

475,681

9.89

1.00

(reference)

1.00

(reference)

  Yes

137

15,463

8.86

1.29

(1.09, 1.54)**

1.53

(1.29, 1.81)***

 Depression

  No

4388

450,667

9.74

1.00

(reference)

1.00

(reference)

  Yes

452

40,478

11.17

1.62

(1.47, 1.78)***

1.35

(1.22, 1.49)***

  1. PY: person-year; IR: incidence rate, per 1000 person-years; cHR: crude hazard ratio; aHR: adjusted hazard ratio, adjusted hazard ratio, adjusted for age, sex, index year and comorbidities; CI: confidence interval; *p < 0.05, **p < 0.01, ***p < 0.001